Assessing the diagnostic accuracy of unilateral systematic biopsy combined with targeted biopsy
In conclusion, our study showed that ips-SB+TB was comparable to SB+TB in detecting csPCa. The results of this study provide valuable insight into the potential of ips-SB+TB as an alternative to SB+TB.
Authors
- Jinjiang Jiang (ORCID: https://orcid.org/0009-0006-5329-8420)
- Qiang Wei (ORCID: https://orcid.org/0000-0001-8170-5587)
- Zihao Chen
- B. Chen (ORCID: https://orcid.org/0000-0001-9158-8433)
- Ruoxuan Liu (ORCID: https://orcid.org/0000-0001-5069-7211)
- Qiyou Wu (ORCID: https://orcid.org/0000-0002-9730-5382)
- Bo Tang (ORCID: https://orcid.org/0000-0003-4089-5155)
- Qinghai Huang (ORCID: https://orcid.org/0000-0002-5612-5190)
- Jin Yao (ORCID: https://orcid.org/0000-0002-4595-6976)
- Chunlei He (ORCID: https://orcid.org/0009-0002-2319-0604)
- Xiang Tu
- Jinbao Wang
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Community Health Center (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-08-19
- DOI
- https://doi.org/10.3389/fonc.2025.1599869
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China